OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
12 Settembre 2024 - 1:05PM
OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:
KIDS), a company focused exclusively on advancing the field of
pediatric orthopedics, announced today the launch of its Enabling
Technologies division. The Enabling Technologies division will
leverage the company's core mission of addressing unmet pediatric
needs in orthopedics and apply this focus to new areas within
digital health and advanced technology. Led by industry veteran,
Kevin Unger, this new division is set to differentiate
OrthoPediatrics' core business, generate sustainable revenue
growth, and access new markets and specialties beyond orthopedics.
OrthoPediatrics has already made significant
strides in the field through its distribution of the 7D Flash™
Navigation System, and partnership with 3D Side, S.A. for
patient-specific cutting guides. These innovations have laid a
strong foundation for the Enabling Technologies division. The
company is poised to build on this success with the upcoming launch
of two groundbreaking technology platforms:
- Playbook: A
cutting-edge surgical workflow and outcome optimization platform
designed to enhance surgical planning, collaboration, and
intraoperative workflow. Playbook aims to revolutionize how
surgeries are planned and executed, resulting in improved outcomes
and more efficient processes.
- Robotic-Assistance for
Cochlear Implant Technology: OrthoPediatrics has partnered
with iotaMotion, Inc. to bring a robotic-assisted insertion system
designed to enhance the cochlear implant surgery. This technology
offers a slow electrode array insertion that is agnostic to
cochlear implant manufacturer, providing greater control and
precision for pediatric patients.
"We are thrilled to introduce the new Enabling
Technologies division, which will help us expand our ability to
positively impact more children and provide significant long-term
growth opportunities," said David Bailey, CEO of OrthoPediatrics.
"This marks an exciting step forward in our commitment to
innovation and helping kids. We believe these advancements will not
only support our mission to improve pediatric care but also
position us at the forefront of the pediatric digital health and
enabling technologies sectors."
Investor Day Details: The
Company will host an investor day at 10:30am E.T. on September 12,
2024, in New York, New York. The presentation will also be webcast
live and a recording will be available on the Events &
Presentations section on the investor relations website of
www.orthopediatrics.com.ss
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an orthopedic
company focused exclusively on advancing the field of pediatric
orthopedics. As such it has developed the most comprehensive
product offering to the pediatric orthopedic market to improve the
lives of children with orthopedic conditions. OrthoPediatrics
currently markets greater than 70 products that serve three of the
largest categories within the pediatric orthopedic market. This
product offering spans trauma and deformity, scoliosis, and sports
medicine/other procedures. OrthoPediatrics’ global sales
organization is focused exclusively on pediatric orthopedics and
distributes its products in the United States and over 70 countries
outside the United States. For more information, please visit
www.orthopediatrics.com.
Investor ContactPhilip Trip
TaylorGilmartin Groupphilip@gilmartinir.com415-937-5406
Grafico Azioni OrthoPediatrics (NASDAQ:KIDS)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni OrthoPediatrics (NASDAQ:KIDS)
Storico
Da Nov 2023 a Nov 2024